Published 24 September 2008, doi:10.1136/bmj.a1239
Cite this as: BMJ 2008;337:a1239

Practice

Guidelines

Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance

¹ National Collaborating Centre for Mental Health, Research and Training Unit, London E1 8AA , ² Royal College of Psychiatrists’ Research and Training Unit, London E1 8AA , ³ Sheffield Care Trust, Sheffield , ⁴ Department of Child and Adolescent Psychiatry, King’s College London, Institute of Psychiatry, London SE5 8AF, ⁵ British Psychological Society—CORE, Sub-Department of Clinical Health Psychology, University College London, London WC1E 7HB

The first 150 words of the full text of this article appear below.

Attention-deficit/hyperactivity disorder (ADHD) is a common childhood condition that may affect different areas of the child’s life, seriously impairing academic achievement, peer relationships, and self care. Many affected children become socially isolated and develop conduct problems. Some 15% of children with ADHD will still have the condition in adulthood, and even more will develop a personality disorder and/or a substance misuse disorder in adulthood.^{1 2 3}

Diagnosis rates for ADHD and prescriptions of stimulant medication have risen substantially in England during the past decade, with 220 000 prescriptions for stimulants (costing about £5m (6.3m; $9.4m)) in 1998 and 418 300 (almost £13m) in 2004.⁴ The prescription of stimulants, which are potential drugs of misuse, to children remains controversial, with concerns about their safety and the potential for misuse and diversion (where the drug is passed on to others for non-prescription use).This article summarises the most recent recommendations from the National Institute . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

NICE recommendations are not evidence based and could expose many to unnecessary harm

Sami Timimi, Jon Jureidini, and Jonathan Leo
BMJ 2008 337: a2284. [Extract] [Full Text]

Diversion and abuse of methylphenidate in light of new guidance

Harry R Sumnall, Kerry Woolfall, Jon Cole, Adam Mackridge, and Jim McVeigh
BMJ 2008 337: a2287. [Extract] [Full Text]

NICE should produce guidance on infant mental health

Shirley A Gracias
BMJ 2008 337: a2288. [Extract] [Full Text]

Commentary: Controversies in NICE guidance on attention-deficit/hyperactivity disorder

Anne Thompson
BMJ 2008 337: a1466. [Extract] [Full Text]

This article has been cited by other articles:

• Timimi, S., Jureidini, J., Leo, J. (2008). NICE recommendations are not evidence based and could expose many to unnecessary harm. BMJ 337: a2284-a2284 [Full text]  
• Sumnall, H. R, Woolfall, K., Cole, J., Mackridge, A., McVeigh, J. (2008). Diversion and abuse of methylphenidate in light of new guidance. BMJ 337: a2287-a2287 [Full text]  
• Gracias, S. A (2008). NICE should produce guidance on infant mental health. BMJ 337: a2288-a2288 [Full text]  

Rapid Responses:

Read all Rapid Responses

NICE recommendations on ADHD are not evidence based and could expose many to unnecessary harm

Sami Timimi, et al.
bmj.com, 24 Sep 2008 [Full text]

Diversion and abuse of Methylphenidate in light of new NICE guidance

Harry R Sumnall, et al.
bmj.com, 25 Sep 2008 [Full text]

NICE should produce guidance on Infant Mental Health

Shirley A Gracias, et al.
bmj.com, 30 Sep 2008 [Full text]

ADHD is Neither a Disease or a Disorder

Fred A., Jr. Baughman
bmj.com, 1 Oct 2008 [Full text]

Online poll

Find out more on doc2doc >>